Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 555

1.

Prevalence, incidence and future projection of diabetic eye disease in Europe: a systematic review and meta-analysis.

Li JQ, Welchowski T, Schmid M, Letow J, Wolpers C, Pascual-Camps I, Holz FG, Finger RP.

Eur J Epidemiol. 2019 Sep 12. doi: 10.1007/s10654-019-00560-z. [Epub ahead of print]

PMID:
31515657
2.

Histological Corneal Alterations in Keratoconus After Crosslinking-Expansion of Findings.

Müller PL, Loeffler KU, Messmer E, Holz FG, Perdikakis G, Kohlhaas M, Herwig-Carl MC.

Cornea. 2019 Sep 9. doi: 10.1097/ICO.0000000000002144. [Epub ahead of print]

PMID:
31513045
3.

[Dry Age-Related Macular Degeneration - Epidemiology and Classification].

Fleckenstein M, Thiele S, Pfau M, Schmitz-Valckenberg S, Holz FG.

Klin Monbl Augenheilkd. 2019 Sep;236(9):1068-1075. doi: 10.1055/a-0958-9621. Epub 2019 Sep 11. German.

PMID:
31509857
4.

Inter-Device Comparison of Blue-Light Autofluorescence in Optic Disc Drusen.

Turski CA, Holz FG, Brinkmann CK.

Ophthalmologica. 2019 Sep 6:1-10. doi: 10.1159/000501860. [Epub ahead of print]

PMID:
31494652
5.

Eye tracking-based estimation and compensation of chromatic offsets for multi-wavelength retinal microstimulation with foveal cone precision.

Domdei N, Linden M, Reiniger JL, Holz FG, Harmening WM.

Biomed Opt Express. 2019 Jul 18;10(8):4126-4141. doi: 10.1364/BOE.10.004126. eCollection 2019 Aug 1.

6.

Quantification of Retinal and Choriocapillaris Perfusion in Different Stages of Macular Telangiectasia Type 2.

Tzaridis S, Wintergerst MWM, Mai C, Heeren TFC, Holz FG, Charbel Issa P, Herrmann P.

Invest Ophthalmol Vis Sci. 2019 Aug 1;60(10):3556-3562. doi: 10.1167/iovs.19-27055.

PMID:
31415079
7.

Ultraviolet Radiation Exposure of One Eye Stimulates Sympathizing Expression of Neurokinin-1 Receptor but Not Monocyte Chemoattractant Protein-1 in the Partner Eye.

Gross J, Willimsky E, Wegener AR, Kronschläger M, Schönfeld CL, Holz FG, Meyer LM.

Ophthalmic Res. 2019 Aug 13:1-13. doi: 10.1159/000501320. [Epub ahead of print]

PMID:
31408874
8.

Foveal Sparing in Central Retinal Dystrophies.

Bax NM, Valkenburg D, Lambertus S, Klevering BJ, Boon CJF, Holz FG, Cremers FPM, Fleckenstein M, Hoyng CB, Lindner M; for the Foveal Sparing Atrophy Study Team (FAST).

Invest Ophthalmol Vis Sci. 2019 Aug 1;60(10):3456-3467. doi: 10.1167/iovs.18-26533.

PMID:
31398255
9.

Acute Retinopathy in Pseudoxanthoma Elasticum.

Gliem M, Birtel J, Müller PL, Hendig D, Faust I, Herrmann P, Holz FG, Adamus G, Charbel Issa P.

JAMA Ophthalmol. 2019 Aug 8. doi: 10.1001/jamaophthalmol.2019.2910. [Epub ahead of print]

PMID:
31393536
10.

Anatomical and functional outcomes following switching from aflibercept to ranibizumab in neovascular age-related macular degeneration in Europe: SAFARI study.

Gale RP, Pearce I, Eter N, Ghanchi F, Holz FG, Schmitz-Valckenberg S, Balaskas K, Burton BJL, Downes SM, Eleftheriadis H, George S, Gilmour D, Hamilton R, Lotery AJ, Patel N, Prakash P, Santiago C, Thomas S, Varma D, Walters G, Williams M, Wolf A, Zakri RH, Igwe F, Ayan F.

Br J Ophthalmol. 2019 Aug 5. pii: bjophthalmol-2019-314251. doi: 10.1136/bjophthalmol-2019-314251. [Epub ahead of print]

11.

Artificial intelligence for morphology-based function prediction in neovascular age-related macular degeneration.

von der Emde L, Pfau M, Dysli C, Thiele S, Möller PT, Lindner M, Schmid M, Fleckenstein M, Holz FG, Schmitz-Valckenberg S.

Sci Rep. 2019 Jul 31;9(1):11132. doi: 10.1038/s41598-019-47565-y.

12.

Central serous chorioretinopathy: Towards an evidence-based treatment guideline.

van Rijssen TJ, van Dijk EHC, Yzer S, Ohno-Matsui K, Keunen JEE, Schlingemann RO, Sivaprasad S, Querques G, Downes SM, Fauser S, Hoyng CB, Piccolino FC, Chhablani JK, Lai TYY, Lotery AJ, Larsen M, Holz FG, Freund KB, Yannuzzi LA, Boon CJF.

Prog Retin Eye Res. 2019 Jul 15. pii: S1350-9462(18)30094-6. doi: 10.1016/j.preteyeres.2019.07.003. [Epub ahead of print] Review.

13.

Impact of Baseline Retinal Nonperfusion and Macular Retinal Capillary Nonperfusion on Outcomes in the COPERNICUS and GALILEO Studies.

Feltgen N, Ogura Y, Boscia F, Holz FG, Korobelnik JF, Brown DM, Heier JS, Stemper B, Rittenhouse KD, Asmus F, Ahlers C, Vitti R, Saroj N, Mitchell P.

Ophthalmol Retina. 2019 Jul;3(7):553-560. doi: 10.1016/j.oret.2019.02.010. Epub 2019 Feb 27.

PMID:
31277796
14.

Incidence of Rhegmatogenous Retinal Detachment in Europe - A Systematic Review and Meta-Analysis.

Li JQ, Welchowski T, Schmid M, Holz FG, Finger RP.

Ophthalmologica. 2019;242(2):81-86. doi: 10.1159/000499489. Epub 2019 Jun 21.

PMID:
31230058
15.

Determinants of Macular Layers and Optic Disc Characteristics on SD-OCT: The Rhineland Study.

Mauschitz MM, Holz FG, Finger RP, Breteler MMB.

Transl Vis Sci Technol. 2019 Jun 4;8(3):34. doi: 10.1167/tvst.8.3.34. eCollection 2019 May.

16.

Assessment of Novel Genome-Wide Significant Gene Loci and Lesion Growth in Geographic Atrophy Secondary to Age-Related Macular Degeneration.

Grassmann F, Harsch S, Brandl C, Kiel C, Nürnberg P, Toliat MR, Fleckenstein M, Pfau M, Schmitz-Valckenberg S, Holz FG, Chew EY, Swaroop A, Ratnapriya R, Klein ML, Mulyukov Z, Zamiri P, Weber BHF.

JAMA Ophthalmol. 2019 May 23. doi: 10.1001/jamaophthalmol.2019.1318. [Epub ahead of print]

PMID:
31120506
17.

Habitual higher order aberrations affect Landolt but not Vernier acuity.

Reiniger JL, Lobecke AC, Sabesan R, Bach M, Verbakel F, de Brabander J, Holz FG, Berendschot TTJM, Harmening WM.

J Vis. 2019 May 1;19(5):11. doi: 10.1167/19.5.11.

18.

[Development and validation of novel clinical endpoints in intermediate age-related macular degeneration in MACUSTAR].

Terheyden JH, Finger RP, Schmitz-Valckenberg S, Agostini H, Dahlke C, Kuehlewein L, Lang GE, Pauleikhoff D, Wolf A, Boettger MK, Luhmann UFO, Asmus F, Holz FG; MACUSTAR-Konsortium.

Ophthalmologe. 2019 May 13. doi: 10.1007/s00347-019-0907-1. [Epub ahead of print] Review. German.

PMID:
31087116
19.

The ocular phenotype in primary hyperoxaluria type 1.

Birtel J, Herrmann P, Garrelfs SF, Dulz S, Atiskova Y, Diederen RM, Gliem M, Brinkert F, Holz FG, Boon CJF, Hoppe B, Charbel Issa P.

Am J Ophthalmol. 2019 May 10. pii: S0002-9394(19)30218-1. doi: 10.1016/j.ajo.2019.04.036. [Epub ahead of print]

PMID:
31078535
20.

Evaluating the Impact of Intravitreal Aflibercept on Diabetic Retinopathy Progression in the VIVID-DME and VISTA-DME Studies.

Mitchell P, McAllister I, Larsen M, Staurenghi G, Korobelnik JF, Boyer DS, Do DV, Brown DM, Katz TA, Berliner A, Vitti R, Zeitz O, Metzig C, Lu C, Holz FG.

Ophthalmol Retina. 2018 Oct;2(10):988-996. doi: 10.1016/j.oret.2018.02.011. Epub 2018 Mar 31.

PMID:
31047501
21.

Dark-Adapted Two-Color Fundus-Controlled Perimetry in Macular Telangiectasia Type 2.

Heeren TFC, Tzaridis S, Bonelli R, Pfau M, Fruttiger M, Okada M, Egan C, Charbel Issa P, Holz FG.

Invest Ophthalmol Vis Sci. 2019 Apr 1;60(5):1760-1767. doi: 10.1167/iovs.18-25360.

PMID:
31022297
22.

Determinants of Reading Performance in Eyes with Foveal-Sparing Geographic Atrophy.

Lindner M, Pfau M, Czauderna J, Goerdt L, Schmitz-Valckenberg S, Holz FG, Fleckenstein M.

Ophthalmol Retina. 2019 Mar;3(3):201-210. doi: 10.1016/j.oret.2018.11.005. Epub 2018 Nov 22.

PMID:
31014695
23.

Optical coherence tomography angiography (OCT-A) in an animal model of laser-induced choroidal neovascularization.

Meyer JH, Larsen PP, Strack C, Harmening WM, Krohne TU, Holz FG, Schmitz-Valckenberg S.

Exp Eye Res. 2019 Jul;184:162-171. doi: 10.1016/j.exer.2019.04.002. Epub 2019 Apr 16.

24.

HAWK and HARRIER: Phase 3, Multicenter, Randomized, Double-Masked Trials of Brolucizumab for Neovascular Age-Related Macular Degeneration.

Dugel PU, Koh A, Ogura Y, Jaffe GJ, Schmidt-Erfurth U, Brown DM, Gomes AV, Warburton J, Weichselberger A, Holz FG; HAWK and HARRIER Study Investigators.

Ophthalmology. 2019 Apr 12. pii: S0161-6420(18)33018-5. doi: 10.1016/j.ophtha.2019.04.017. [Epub ahead of print]

25.

Genetic testing in patients with retinitis pigmentosa: Features of unsolved cases.

Birtel J, Gliem M, Oishi A, Müller PL, Herrmann P, Holz FG, Mangold E, Knapp M, Bolz HJ, Charbel Issa P.

Clin Exp Ophthalmol. 2019 Aug;47(6):779-786. doi: 10.1111/ceo.13516. Epub 2019 May 8.

PMID:
30977268
26.

Spatial intratumor heterogeneity in uveal melanoma: Tumor cell subtypes with a presumed invasive potential exhibit a particular epigenetic staining reaction.

Herwig-Carl MC, Sharma A, Höller T, Holz FG, Schlitter AM, Loeffler KU.

Exp Eye Res. 2019 May;182:175-181. doi: 10.1016/j.exer.2019.04.001. Epub 2019 Apr 4.

27.

Retinal findings in carriers of monoallelic ABCC6 mutations.

Gliem M, Wieg I, Birtel J, Müller PL, Faust I, Hendig D, Holz FG, Finger RP, Charbel Issa P.

Br J Ophthalmol. 2019 Mar 28. pii: bjophthalmol-2018-313448. doi: 10.1136/bjophthalmol-2018-313448. [Epub ahead of print]

PMID:
30923132
28.

Retinal Hemorrhages in Shaken Baby Syndrome.

Wang L, Petrak M, Holz FG, Müller A, Krohne TU.

J Pediatr. 2019 Apr;207:256. doi: 10.1016/j.jpeds.2018.12.054. No abstract available.

PMID:
30922497
29.

Awareness of Age-Related Macular Degeneration in Community-Dwelling Elderly Persons in Germany.

Heinemann M, Welker SG, Li JQ, Wintergerst MWM, Turski GN, Turski CA, Holz FG, Finger RP.

Ophthalmic Epidemiol. 2019 Aug;26(4):238-243. doi: 10.1080/09286586.2019.1597898. Epub 2019 Mar 28.

PMID:
30917716
30.

Correction to: Visual impairment and blindness in institutionalized elderly in Germany.

Larsen PP, Thiele S, Krohne TU, Ziemssen F, Krummenauer F, Holz FG, Finger RP; OVIS-Study Group.

Graefes Arch Clin Exp Ophthalmol. 2019 May;257(5):1057. doi: 10.1007/s00417-019-04277-3.

PMID:
30838438
31.

Right-angled vessels in macular telangiectasia type 2.

Tzaridis S, Heeren T, Mai C, Thiele S, Holz FG, Charbel Issa P, Herrmann P.

Br J Ophthalmol. 2019 Feb 26. pii: bjophthalmol-2018-313364. doi: 10.1136/bjophthalmol-2018-313364. [Epub ahead of print]

32.

Efficacy of novel selective NLRP3 inhibitors in human and murine retinal pigment epithelial cells.

Wang L, Schmidt S, Larsen PP, Meyer JH, Roush WR, Latz E, Holz FG, Krohne TU.

J Mol Med (Berl). 2019 Apr;97(4):523-532. doi: 10.1007/s00109-019-01753-5. Epub 2019 Feb 10.

PMID:
30739141
33.

Estimating Retinal Sensitivity Using Optical Coherence Tomography With Deep-Learning Algorithms in Macular Telangiectasia Type 2.

Kihara Y, Heeren TFC, Lee CS, Wu Y, Xiao S, Tzaridis S, Holz FG, Charbel Issa P, Egan CA, Lee AY.

JAMA Netw Open. 2019 Feb 1;2(2):e188029. doi: 10.1001/jamanetworkopen.2018.8029.

34.

[Epidemiology of severe visual impairment and blindness of old people in Germany].

Mauschitz MM, Li JQ, Larsen PP, Köberlein-Neu J, Holz FG, Breteler MMB, Finger RP.

Ophthalmologe. 2019 Feb;116(2):201-212. doi: 10.1007/s00347-019-0853-y. German.

PMID:
30715591
35.

Near-Infrared Autofluorescence in Choroideremia: Anatomic and Functional Correlations.

Birtel J, Salvetti AP, Jolly JK, Xue K, Gliem M, Müller PL, Holz FG, MacLaren RE, Charbel Issa P.

Am J Ophthalmol. 2019 Mar;199:19-27. doi: 10.1016/j.ajo.2018.10.021. Epub 2018 Oct 26.

PMID:
30713139
36.

Spectrally Resolved Fundus Autofluorescence in ABCA4-Related Retinopathy.

Dysli C, Müller PL, Birtel J, Holz FG, Herrmann P.

Invest Ophthalmol Vis Sci. 2019 Jan 2;60(1):274-281. doi: 10.1167/iovs.18-25755.

PMID:
30657522
37.

Mesopic and Dark-Adapted Two-Color Fundus-Controlled Perimetry in Choroidal Neovascularization Secondary to Age-Related Macular Degeneration.

von der Emde L, Pfau M, Thiele S, Möller PT, Hassenrik R, Fleckenstein M, Holz FG, Schmitz-Valckenberg S.

Transl Vis Sci Technol. 2018 Jan 9;8(1):7. doi: 10.1167/tvst.8.1.7. eCollection 2019 Jan.

38.

[Bilateral multifocal pigment epithelial detachments associated with inhaled corticosteroids].

Bindewald-Wittich A, Milojcic C, Pfau M, Holz FG.

Ophthalmologe. 2019 Sep;116(9):887-892. doi: 10.1007/s00347-018-0848-0. German.

PMID:
30627764
39.

Survival and functionality of xeno-free human embryonic stem cell-derived retinal pigment epithelial cells on polyester substrate after transplantation in rabbits.

Ilmarinen T, Thieltges F, Hongisto H, Juuti-Uusitalo K, Koistinen A, Kaarniranta K, Brinken R, Braun N, Holz FG, Skottman H, Stanzel BV.

Acta Ophthalmol. 2019 Aug;97(5):e688-e699. doi: 10.1111/aos.14004. Epub 2018 Dec 28.

PMID:
30593729
40.

Basal cell carcinomas developing independently from BAP1-tumor predisposition syndrome in a patient with bilateral uveal melanoma: Diagnostic challenges to identify patients with BAP1-TPDS.

Melzer C, Sharma A, Peters S, Aretz S, Biswas A, Holz FG, Loeffler KU, Herwig-Carl MC.

Genes Chromosomes Cancer. 2019 Jun;58(6):357-364. doi: 10.1002/gcc.22724. Epub 2019 Jan 23.

PMID:
30578689
41.

Next-generation sequencing identifies unexpected genotype-phenotype correlations in patients with retinitis pigmentosa.

Birtel J, Gliem M, Mangold E, Müller PL, Holz FG, Neuhaus C, Lenzner S, Zahnleiter D, Betz C, Eisenberger T, Bolz HJ, Charbel Issa P.

PLoS One. 2018 Dec 13;13(12):e0207958. doi: 10.1371/journal.pone.0207958. eCollection 2018.

42.

Prevalence of Retinal Vein Occlusion in Europe: A Systematic Review and Meta-Analysis.

Li JQ, Terheyden JH, Welchowski T, Schmid M, Letow J, Wolpers C, Holz FG, Finger RP.

Ophthalmologica. 2019;241(4):183-189. doi: 10.1159/000494224. Epub 2018 Dec 5.

PMID:
30517942
43.

Visual impairment and blindness in institutionalized elderly in Germany.

Larsen PP, Thiele S, Krohne TU, Ziemssen F, Krummenauer F, Holz FG, Finger RP; OVIS-Study Group.

Graefes Arch Clin Exp Ophthalmol. 2019 Feb;257(2):363-370. doi: 10.1007/s00417-018-4196-1. Epub 2018 Nov 27. Erratum in: Graefes Arch Clin Exp Ophthalmol. 2019 Mar 6;:.

PMID:
30483949
44.

Retest Reliability of Mesopic and Dark-Adapted Microperimetry in Patients With Intermediate Age-Related Macular Degeneration and Age-Matched Controls.

Welker SG, Pfau M, Heinemann M, Schmitz-Valckenberg S, Holz FG, Finger RP.

Invest Ophthalmol Vis Sci. 2018 Mar 20;59(4):AMD152-AMD159. doi: 10.1167/iovs.18-23878.

PMID:
30372731
45.

[Baseline diagnostics and initial treatment decision for anti-vascular endothelial growth factor treatment in retinal diseases : Comparison between results by study physician and reading centers (ORCA/OCEAN study)].

Brinkmann CK, Chang P, Schick T, Heimes B, Vögeler J, Haegele B, Kirchhof B, Holz FG, Pauleikhoff D, Ziemssen F, Liakopoulos S, Spital G, Schmitz-Valckenberg S.

Ophthalmologe. 2019 Aug;116(8):753-765. doi: 10.1007/s00347-018-0805-y. German.

PMID:
30367231
46.

ASSESSMENT OF ANATOMICAL AND FUNCTIONAL OUTCOMES WITH OCRIPLASMIN TREATMENT IN PATIENTS WITH VITREOMACULAR TRACTION WITH OR WITHOUT MACULAR HOLES: Results of OVIID-1 Trial.

Tadayoni R, Holz FG, Zech C, Liu X, Spera C, Stalmans P.

Retina. 2018 Oct 9. doi: 10.1097/IAE.0000000000002332. [Epub ahead of print]

PMID:
30308558
47.

MESOPIC AND DARK-ADAPTED TWO-COLOR FUNDUS-CONTROLLED PERIMETRY IN GEOGRAPHIC ATROPHY SECONDARY TO AGE-RELATED MACULAR DEGENERATION.

Pfau M, Müller PL, von der Emde L, Lindner M, Möller PT, Fleckenstein M, Holz FG, Schmitz-Valckenberg S.

Retina. 2018 Oct 8. doi: 10.1097/IAE.0000000000002337. [Epub ahead of print]

PMID:
30300264
48.

Macular spatial distribution of preserved autofluorescence in patients with choroideremia.

Hariri AH, Ip MS, Girach A, Lam BL, Fischer MD, Sankila EM, Pennesi ME, Holz FG, Maclaren RE, Birch DG, Hoyng CB, MacDonald IM, Black GC, Tsang SH, Bressler NM, Stepien KE, Larsen M, Gorin MB, Meunier I, Webster AR, Sadda S; For Natural History of the Progression of Choroideremia (NIGHT) Study Group.

Br J Ophthalmol. 2019 Jul;103(7):933-937. doi: 10.1136/bjophthalmol-2018-312620. Epub 2018 Oct 8.

PMID:
30297337
49.

Comparison of Green Versus Blue Fundus Autofluorescence in ABCA4-Related Retinopathy.

Müller PL, Pfau M, Mauschitz MM, Möller PT, Birtel J, Chang P, Gliem M, Schmitz-Valckenberg S, Fleckenstein M, Holz FG, Herrmann P.

Transl Vis Sci Technol. 2018 Oct 1;7(5):13. doi: 10.1167/tvst.7.5.13. eCollection 2018 Sep.

50.

[Imaging and molecular genetic diagnostics for the characterization of retinal dystrophies].

Birtel J, Gliem M, Holz FG, Herrmann P.

Ophthalmologe. 2018 Dec;115(12):1021-1027. doi: 10.1007/s00347-018-0779-9. Review. German.

PMID:
30259088

Supplemental Content

Support Center